Eton Bioscience Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Eton Bioscience's estimated annual revenue is currently $12.6M per year.(i)
  • Eton Bioscience's estimated revenue per employee is $155,000

Employee Data

  • Eton Bioscience has 81 Employees.(i)
  • Eton Bioscience grew their employee count by 5% last year.

Eton Bioscience's People

NameTitleEmail/Phone
1
Director Sales & Business DevelopmentReveal Email/Phone
2
North Carolina Branch ManagerReveal Email/Phone
3
Project ManagerReveal Email/Phone
4
Web DeveloperReveal Email/Phone
5
Laboratory TechnicianReveal Email/Phone
6
Laboratory TechnicianReveal Email/Phone
7
Regional Account ExecutiveReveal Email/Phone
8
Laboratory TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Eton Bioscience?

Eton Bioscience Inc. is a biotech company specializing in DNA sequencing and oligo synthesis services nationwide. Founded in 2003 in San Diego, California, we have been providing scientists of both academia and industry with a variety of services and products to assist them in research. At Eton we strive to provide only the best through our high quality and reliable services, customer care and competitive pricing. We understand that by developing and utilizing the latest innovative techniques, sustainable practices, and efficiency, we are on the way to becoming the number one DNA sequencing company in the nation. Taking pride in what we do, we deliver science, not words.

keywords:N/A

N/A

Total Funding

81

Number of Employees

$12.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.4M818%N/A
#2
$20.6M8113%N/A
#3
$17M81-41%N/A
#4
$21.9M813%N/A
#5
$7.5M814%N/A